Events and Presentations Events and Presentations Upcoming Events There are no upcoming events available at this time. Past Events June 12, 2020 Stoke Therapeutics at Association for Research in Vision & Ophthalmology Meeting 2020 Supporting Materials Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for the treatment of autosomal dominant optic atrophy 3.7 MB May 12, 2020 Stoke Therapeutics at American Society of Gene and Cell Therapy Annual Meeting March 2, 2020 at 3:30 PM EST Stoke Therapeutics at Cowen 40th Annual Health Care Conference Location Boston, MA Click here for webcast Corporate Presentation Corporate Presentation – June 2020 Genetic Epilepsies Presentations AES2019 cyno pharmacology poster AES2019 mouse efficacy poster Ophthalmology Presentations Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for the treatment of autosomal dominant optic atrophy Poster: Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for treatment of autosomal dominant optic atrophy Toolkit Print Page Email Alerts Contact IR FAQ
Events and Presentations Upcoming Events There are no upcoming events available at this time. Past Events June 12, 2020 Stoke Therapeutics at Association for Research in Vision & Ophthalmology Meeting 2020 Supporting Materials Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for the treatment of autosomal dominant optic atrophy 3.7 MB May 12, 2020 Stoke Therapeutics at American Society of Gene and Cell Therapy Annual Meeting March 2, 2020 at 3:30 PM EST Stoke Therapeutics at Cowen 40th Annual Health Care Conference Location Boston, MA Click here for webcast Corporate Presentation Corporate Presentation – June 2020 Genetic Epilepsies Presentations AES2019 cyno pharmacology poster AES2019 mouse efficacy poster Ophthalmology Presentations Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for the treatment of autosomal dominant optic atrophy Poster: Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for treatment of autosomal dominant optic atrophy
June 12, 2020 Stoke Therapeutics at Association for Research in Vision & Ophthalmology Meeting 2020 Supporting Materials Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for the treatment of autosomal dominant optic atrophy 3.7 MB
Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for the treatment of autosomal dominant optic atrophy 3.7 MB
March 2, 2020 at 3:30 PM EST Stoke Therapeutics at Cowen 40th Annual Health Care Conference Location Boston, MA Click here for webcast
Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for the treatment of autosomal dominant optic atrophy
Poster: Antisense oligonucleotide mediated increase of OPA1 expression using TANGO technology for treatment of autosomal dominant optic atrophy